Diagnostic Value of Cyclophilin A in Acute Ischemic Stroke

Karaca, Yunus; Tatlı, Özgür; Eryiğit, Umut; Aksut, Nurhak; Şahin, Ali; Menteşe, Ahmet; Altay, Diler Us; Beslioglu, Necla; Karataş, Mevlüt; Örem, Asım

doi:10.5152/eajem.2017.35119

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our second finding is the absence of any difference between the groups in terms of CYPA levels. Several publications have reported that CYPA levels are affected by various pathologies, including coronary artery disease, acute ischemic stroke, and aortic aneurysm [15][16][17]. The underlying pathogenesis involves the release of reactive oxygen products as a result of thrombosis from endothelial cells in the arterial wall, and these products' increasing the release of CYPA from endothelial cells [18,19].…”

Section: Discussionmentioning

confidence: 99%

The diagnostic value of cyclophilin A and VAP-1 in patients with suspected pulmonary embolism

Şahin¹,

Aşık²,

Tatlı³

et al. 2018

Ortadogu Tıp Derg

Self Cite

View full text Add to dashboard Cite

Aim: To investigate the diagnostic value of the biochemical markers cyclophilin A (CYPA) and vascular adhesion protein-1 (VAP-1), associated with endothelial dysfunction, platelet adhesion, and arterial thrombus in pulmonary embolism (PE), in whose pathophysiology platelet activation and aggregation resulting from endothelial damage are known to be involved. Material and Method: Serum CYPA and VAP-1 levels of 165 patients presenting to the emergency department with suspected acute PE and with presence of PE investigated at spiral computerized tomography angiography were measured in this prospective clinical study. These patients were assigned into two groups, PE (+) and PE (-), based on the computerized tomography results, and their CYPA and VAP-1 levels were then compared. Results: Comparison of the two groups' measurements revealed a significant difference in terms of VAP-1 levels (p=0.0001), but none for CYPA (p=0.381). Conclusion: Diagnostic value was determined for serum VAP-1 levels in acute PE, but we couldn't detect any diagnostic value for CYPA in patients with acute PE.

show abstract